
Obnyx contains Enzalutamide 40mg, an oral anti-cancer medication used to treat metastatic castration-resistant prostate cancer (mCRPC) and non-metastatic castration-resistant prostate cancer (nmCRPC) in adult men.
| Generic Name | Enzalutamide |
| Manufacturer | Zydus Cadila |
| Packing | 28 Capsules |
| Prescribed For | Prostate Cancer |
| Availability | In Stock |




As a fully licensed supplier of high-quality generic oncology medicines, we provide Obnyx (Enzalutamide 40 mg Capsules), widely used for the treatment of advanced prostate cancer.
We ensure safe, consistent, and timely bulk supply of anticancer drugs, including Enzalutamide (Generic Xtandi), to hospitals, clinics, pharmacies, healthcare providers, physicians, NGOs, and authorized buyers in over 80 countries worldwide. Our distribution network spans Latin America, Africa, Asia, Europe, the Middle East, and North America, covering regions such as Mexico, Brazil, Colombia, Peru, Chile, UAE, Saudi Arabia, Egypt, South Africa, Namibia, Kenya, Nigeria, Singapore, Vietnam, Thailand, the Philippines, Canada, and many more.
Disclaimer
This website operates in compliance with applicable pharmaceutical laws. All content and data available on this website are intended solely for informational purposes. The information provided is not a substitute for professional medical advice, diagnosis, or treatment. Information provided here is for general awareness and does not replace medical advice. We strongly encourage you to consult a qualified healthcare professional for guidance.